Delisting riskPopularity #4,921
ELUT · NASDAQ · Biotechnology

Elutia (ELUT)

Develops drug-eluting biomatrices for surgical reconstruction and implanted-device complications.

$0.8102
After-hours close0.00 (0.00%)
At close$0.8102(−5.06%)

Something off on this page? Send us feedback.

Next report
Nov 12, 26
in 51 days
EPS estimate
−$0.15
Revenue estimate
$1.0M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.26−$0.21−$0.26−$0.01−$0.14−$0.17−$0.17Pending
Estimate−$0.25−$0.20−$0.17−$0.16−$0.14−$0.15−$0.15−$0.15
Surprise−4.0%−5.0%−52.9%+93.5%0.0%−13.3%−13.3%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$5.5M$6.0M$6.3M$3.3M$3.3M$3.1M$2.4MPending
Estimate$5.9M$6.7M$7.4M$3.3M$3.3M$3.0M$2.9M$1.0M
Surprise−7.3%−9.3%−15.4%+0.7%−0.9%+3.8%−16.3%

HistoryUpcoming

Date / PeriodEstimateReportedSurprise
Dec 2026−$0.13
Nov 2026−$0.15
Aug 2026−$0.15−$0.17−13.3%
May 2026−$0.15−$0.17−13.3%
Mar 2026−$0.14−$0.140.0%
Nov 2025−$0.16−$0.01+93.5%
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Sep 2022
Aug 2022
Mar 2022
Dec 2021
Sep 2021

The latest year is open to everyone — the 17 quarters behind it read with an account.

Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Dec 2026−$0.13$1.0M
Nov 12, 2026−$0.15$1.0M
Aug 13, 2026−$0.15−$0.17−13.3%$2.9M$2.4M−16.3%+9.4%
May 14, 2026−$0.15−$0.17−13.3%$3.0M$3.1M+3.8%−1.0%
Mar 11, 2026−$0.14−$0.140.0%$3.3M$3.3M−0.9%+5.5%
Nov 6, 2025−$0.16−$0.01+93.5%$3.3M$3.3M+0.7%−5.0%
Aug 14, 2025
May 8, 2025
Mar 6, 2025
Nov 14, 2024
Aug 7, 2024
May 9, 2024
Mar 7, 2024
Nov 13, 2023
Aug 14, 2023
May 10, 2023
Mar 22, 2023
Nov 14, 2022
Sep 29, 2022
Aug 11, 2022
Mar 30, 2022
Dec 30, 2021
Sep 29, 2021

The latest year is open to everyone — the 17 quarters behind it read with an account.